David J. Wambeke's Insider Trades & SAST Disclosures

David J. Wambeke's most recent trade in DiaMedica Therapeutics Inc was a trade of 130,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 1, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
DiaMedica Therapeutics Inc
David J. Wambeke Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2024 130,000 130,000 - - Stock Option (right to buy)
DiaMedica Therapeutics Inc
David J. Wambeke Chief Business Officer Purchase of securities on an exchange or from another person at price $ 3.91 per share. 23 Jun 2023 38,364 507,114 (3%) 0% 3.9 150,003 Voting Common Shares, no par value per share
DiaMedica Therapeutics Inc
David J. Wambeke Chief Business Officer Purchase of securities on an exchange or from another person at price $ 1.60 per share. 10 Apr 2023 468,750 468,750 (3%) 3% 1.6 750,000 Voting Common Shares, no par value per share
DiaMedica Therapeutics Inc
David J. Wambeke Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2023 140,000 140,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades